Denali Advisors LLC Nurix Therapeutics, Inc. Transaction History

Denali Advisors LLC

  • $916 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 19, 2024
BUY
$4.25 - $10.71 $244,375 - $615,825
57,500 New
57,500 $593,000
Q4 2022

Feb 09, 2023
BUY
$9.86 - $14.59 $22,678 - $33,557
2,300 Added 63.89%
5,900 $64,000
Q3 2022

Oct 25, 2022
BUY
$12.33 - $19.81 $44,388 - $71,316
3,600 New
3,600 $47,000

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $923M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Denali Advisors LLC Portfolio

Follow Denali Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Denali Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Denali Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email